Optimization of a protocol for the evaluation of antibody responses to human papillomavirus (HPV) vaccination in low-resource settings
Abstract Introduction Available human papillomavirus (HPV) vaccines could have an important primary role in cervical cancer prevention once their long-term immunogenicity and safety are evaluated at the population level. The aim of this study was to optimize an assay to be used in evaluating the lon...
Main Authors: | Emmanuel Timmy Donkoh, Edward Tieru Dassah, Ellis Owusu-Dabo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | BMC Women's Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12905-022-01821-y |
Similar Items
-
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study
by: Ingrid Herta Rotstein Grein, et al.
Published: (2020-11-01) -
Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
by: Ana Gradissimo, et al.
Published: (2021-08-01) -
Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)
by: Juan J. Hernandez-Aguado, et al.
Published: (2022-03-01) -
Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study
by: Oksana Debrah, et al.
Published: (2021-10-01) -
Investigation on Spontaneous Abortion and Human Papillomavirus Infection
by: Mauro Tognon, et al.
Published: (2020-08-01)